Investigation of endometrial adenocarcinoma showed that CD103 expression clearly delineated CD8 T cells localized to intratumoral regions (as opposed to stromal regions), and was an independent predictor of improved survival, particularly for high risk disease (90). The gene discussed is CD8A; the disease is endometrium adenocarcinoma.